Home
Immunomedics, Inc.

Immunomedics, Inc. Market Share Analysis for June 2026

Science and Education > Biology

Domainimmunomedics.com

Year Founded1982

Employees201 - 500

Annual Revenue$15M - $25M

Immunomedics, Inc.

Immunomedics, Inc. (including company regionals)

immunomedics.com

See more website traffic and engagement information

Immunomedics, Inc. Revenue up to June 2026 is 15M - 25M

revenue generated by Immunomedics, Inc. top domains

Immunomedics, Inc. top domains revenue over 3 years

Revenue for Immunomedics, Inc. top domains

immunomedics.com15M - 25M

See more with Sales Intelligence

Total visits to Immunomedics, Inc.'s top domains

Understand Immunomedics, Inc. market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Immunomedics, Inc.'s top domains

Analyze Immunomedics, Inc. engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Immunomedics, Inc.'s top domains

See how Immunomedics, Inc. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Immunomedics, Inc. top competitors by domain

Top similar sites in June 2026, ranked by their affinity

enogene.comCompany NameEnoGeneEmployees51 - 200HQUnited States, New York, New YorkAnnual revenue$25M - $50MTotal visits--Science and Education > Biology

Top technologies used by Immunomedics, Inc.

These are the website technologies, by industry, used by Immunomedics, Inc. top domains

Content Management System (3)

WordPress

Conversion & Analytics (2)

Google Analytics

Email Services (2)

Microsoft Exchange Online

Mobile (2)

Meta Viewport

More Technologies

4

See all

News & Signals from Immunomedics, Inc.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsImmunomedics had issues with securities fraud case on Jan 1st '18.In a securities fraud case against Immunomedics, Inc. that has been heavily litigated since 2018, B&L secured a $40 million settlement for investors as co-lead counsel.

NewsTrodelvy acquired Immunomedics for $21B on Jan 1st '20.The FDA’s decision is a win for Gilead, which gained Trodelvy when it paid $21 billion to acquire Immunomedics in 2020.

NewsRoche Canada partners with Immunomedics.Hoffmann-La Roche Ltd. collaborated with Immunomedics to push clinical trials with Trodelvy.